# A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients

> **NCT07101874** · — · COMPLETED · sponsor: **AstraZeneca** · enrollment: 729 (actual)

## Conditions studied

- Biliary Tract Cancer

## Interventions

_None listed._

## Key facts

- **NCT ID:** NCT07101874
- **Lead sponsor:** AstraZeneca
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2025-08-22
- **Primary completion:** 2026-02-28
- **Final completion:** 2026-02-28
- **Target enrollment:** 729 (ACTUAL)
- **Last updated:** 2026-04-17

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07101874

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07101874, "A Study to Evaluate the Association of Biliary Complications and Treatment Duration in Unresectable BTC Patients". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07101874. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*